View of PLEIOTROPIC EFFECTS OF GLP-1 RECEPTOR AGONISTS AND NOVEL INCRETIN-BASED THERAPIES: CARDIOVASCULAR IMPLICATIONS IN OBESITY AND DIABETES

Return to Issue Details PLEIOTROPIC EFFECTS OF GLP-1 RECEPTOR AGONISTS AND NOVEL INCRETIN-BASED THERAPIES: CARDIOVASCULAR IMPLICATIONS IN OBESITY AND DIABETES Download Download PDF